Hoefer IE - Search Results

1

The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.

van Hout GP, Bosch L, Ellenbroek GH, de Haan JJ, van Solinge WW, Cooper MA, Arslan F, de Jager SC, Robertson AA, Pasterkamp G, Hoefer IE. van Hout GP, et al. Among authors: hoefer ie. Eur Heart J. 2017 Mar 14;38(11):828-836. doi: 10.1093/eurheartj/ehw247. Eur Heart J. 2017. PMID: 27432019

2

Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease.

Hoefer IE, Piek JJ, Pasterkamp G. Hoefer IE, et al. Curr Med Chem. 2006;13(9):979-87. doi: 10.2174/092986706776360996. Curr Med Chem. 2006. PMID: 16611079 Review.

3

A new intra-arterial delivery platform for pro-arteriogenic compounds to stimulate collateral artery growth via transforming growth factor-beta1 release.

Grundmann S, van Royen N, Pasterkamp G, Gonzalez N, Tijsma EJ, Piek JJ, Hoefer IE. Grundmann S, et al. Among authors: hoefer ie. J Am Coll Cardiol. 2007 Jul 24;50(4):351-8. doi: 10.1016/j.jacc.2007.03.046. Epub 2007 Jul 10. J Am Coll Cardiol. 2007. PMID: 17659203 Free article.

4

Monocyte toll-like receptor 2 and 4 responses and expression following percutaneous coronary intervention: association with lesion stenosis and fractional flow reserve.

Versteeg D, Hoefer IE, Schoneveld AH, de Kleijn DP, Busser E, Strijder C, Emons M, Stella PR, Doevendans PA, Pasterkamp G. Versteeg D, et al. Among authors: hoefer ie. Heart. 2008 Jun;94(6):770-6. doi: 10.1136/hrt.2007.117259. Epub 2007 Aug 8. Heart. 2008. PMID: 17686802

5

Arteriogenesis: basic mechanisms and therapeutic stimulation.

Grundmann S, Piek JJ, Pasterkamp G, Hoefer IE. Grundmann S, et al. Among authors: hoefer ie. Eur J Clin Invest. 2007 Oct;37(10):755-66. doi: 10.1111/j.1365-2362.2007.01861.x. Epub 2007 Aug 30. Eur J Clin Invest. 2007. PMID: 17764463 Review.

6

Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.

Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G. Schoneveld AH, et al. Atherosclerosis. 2008 Mar;197(1):95-104. doi: 10.1016/j.atherosclerosis.2007.08.004. Epub 2007 Sep 21. Atherosclerosis. 2008. PMID: 17888930

7

Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.

Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP. Timmers L, et al. Among authors: hoefer ie. Circ Res. 2008 Feb 1;102(2):257-64. doi: 10.1161/CIRCRESAHA.107.158220. Epub 2007 Nov 15. Circ Res. 2008. PMID: 18007026

8

Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis.

Bot PT, Hoefer IE, Piek JJ, Pasterkamp G. Bot PT, et al. Among authors: hoefer ie. Curr Med Chem. 2008;15(8):786-91. doi: 10.2174/092986708783955554. Curr Med Chem. 2008. PMID: 18393848 Review.

9

The visualization of the remodelling paradox.

Pasterkamp G, Hoefer I. Pasterkamp G, et al. Eur Heart J. 2008 Jul;29(14):1704-5. doi: 10.1093/eurheartj/ehn201. Epub 2008 Jun 24. Eur Heart J. 2008. PMID: 18577557 No abstract available.

10

The Nuclear Factor-kappa B p50 subunit is involved in flow-induced outward arterial remodeling.

van Keulen JK, Timmers L, van Kuijk LP, Retnam L, Hoefer IE, Pasterkamp G, Lim SK, de Kleijn DP. van Keulen JK, et al. Among authors: hoefer ie. Atherosclerosis. 2009 Feb;202(2):424-30. doi: 10.1016/j.atherosclerosis.2008.05.049. Epub 2008 Jun 5. Atherosclerosis. 2009. PMID: 18617174

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

284 results

Search Page

Filters